Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCRIPT
NCT06120855Active, not recruiting
- Sponsor
- University of Bern
- Start
- Mar 2024
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of cannabis in cannabis use disorder (CUD) (2 arms), sponsored by University of Bern. Primary endpoint: Self-reported cannabis and tobacco smoking abstinence at 6 months. Started Mar 2024; status: active, not recruiting.
02
Drugs
cannabis
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT06120855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06120855.